| Tel Aviv University Future Technology Development L.P. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100240726 | COMPOSITIONS FOR TREATING AMYLOID ASSOCIATED DISEASES - Indole derivatives, compositions including same, and methods utilizing same for the treatment of amyloid associated diseases, such as type II diabetes mellitus, Alzheimer's dementia or diseases, systemic and localized amyloidosis, and prion-related encephalopathies are provided. | 09-23-2010 |
| 20100105608 | Peptides and methods using same for diagnosis and treatment of amyloid-associated disease - Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X-Y or Y-X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions and kits including such peptides as well as methods using same for diagnosing and treating amyloid associated diseases. | 04-29-2010 |
| 20100022459 | Peptides directed for diagnosis and treatment of amyloid-associated diseases - Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X—Y or Y—X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions and kits including such peptides as well as methods using same for diagnosing and treating amyloid associated diseases. | 01-28-2010 |
| 20090209041 | Peptides and methods for inhibiting amyloid formation - A peptide comprising at least 5 amino acid residues and less than 15 amino acid residues, the peptide including an amino acid sequence as set forth in SEQ ID NO: 7 as well as pharmaceutical compositions, kits and methods for diagnosing and treating amyloid associated diseases. | 08-20-2009 |
| 20090142656 | 3-D MICROBATTERIES BASED ON INTERLACED MICRO-CONTAINER STRUCTURES - An electrical energy storage device ( | 06-04-2009 |
| 20090062180 | Glycogen synthase kinase-3 inhibitors - Novel conjugates that are capable of inhibiting GSK-3 activity, a process of producing same, pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions are disclosed. Methods of treating affective disorders using GSK-3 inhibitors are further disclosed. | 03-05-2009 |
| 20080312188 | Glycogen synthase kinase-3 inhibitors - Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions. | 12-18-2008 |
